Igenomix USA Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
70
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
2
Igenomix USA General Information
Description
Provider of genetic testing services intended for reproductive health clinics. The company offers endometrial receptivity arrays, preimplantation genetic testing, carrier genetic screening, and non-invasive prenatal testing, enabling fertility professionals to improve embryo selection and increase the chances of a successful pregnancy.
Contact Information
Website
www.igenomix.com(Operating Subsidiary)
Corporate Office
- Ronda Narciso Monturiol, 11 B
- Parque Tecnológico Paterna
- 46980 Paterna
- Spain
Corporate Office
- Ronda Narciso Monturiol, 11 B
- Parque Tecnológico Paterna
- 46980 Paterna
- Spain
Igenomix USA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Igenomix USA Comparisons
Industry
Financing
Details
Igenomix USA Competitors (41)
One of Igenomix USA’s 41 competitors is Genewiz, a Formerly VC-backed company based in South Plainfield, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genewiz | Formerly VC-backed | South Plainfield, NJ | ||||
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| Exagen | Formerly VC-backed | Vista, CA | ||||
| ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
| MedGenome Labs | Venture Capital-Backed | Bangalore, India |
Igenomix USA Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Igenomix USA Patents
Igenomix USA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4763999-A1 | Methods and reagents for dinstinguishing between uterine tumors | Pending | 18-Dec-2024 | ||
| WO-2026131967-A1 | Methods and reagents for distinguishing between uterine tumors | Pending | 18-Dec-2024 | ||
| EP-4416305-A2 | Methods and reagents for the differential diagnosis of uterine tumors | Pending | 11-Oct-2021 | ||
| WO-2023061914-A2 | Methods and reagents for the differential diagnosis of uterine tumors | Inactive | 11-Oct-2021 | ||
| WO-2023061914-A3 | Methods and reagents for the differential diagnosis of uterine tumors | Inactive | 11-Oct-2021 | C12Q1/6886 |
Igenomix USA Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Igenomix USA Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Igenomix USA Investments (2)
Igenomix USA’s most recent deal was a Joint Venture with Novalbufera Business. The deal was made on 04-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Novalbufera Business | 04-Jun-2021 | Joint Venture | Other Commercial Products | ||
| Access Genomics | 14-Dec-2020 | Buyout/LBO | Laboratory Services (Healthcare) |
Igenomix USA Exits (1)
Igenomix USA’s most recent exit was on 14-Dec-2020 from Access Genomics. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Access Genomics | 14-Dec-2020 | Completed |
|
Igenomix USA FAQs
-
When was Igenomix USA founded?
Igenomix USA was founded in 2011.
-
Where is Igenomix USA headquartered?
Igenomix USA is headquartered in Paterna, Spain.
-
What is the size of Igenomix USA?
Igenomix USA has 70 total employees.
-
What industry is Igenomix USA in?
Igenomix USA’s primary industry is Laboratory Services (Healthcare).
-
Is Igenomix USA a private or public company?
Igenomix USA is a Private company.
-
What is the current valuation of Igenomix USA?
The current valuation of Igenomix USA is .
-
What is Igenomix USA’s current revenue?
The current revenue for Igenomix USA is .
-
Who are Igenomix USA’s investors?
Aleph Capital Partners, Amadeus Capital Partners, Charme Capital Partners, EQT, and are 5 of 7 investors who have invested in Igenomix USA.
-
Who are Igenomix USA’s competitors?
Genewiz, BGI Genomics, Exagen, ARUP Laboratories, and MedGenome Labs are some of the 41 competitors of Igenomix USA.
-
When was Igenomix USA acquired?
Igenomix USA was acquired on 30-Nov-2021.
-
Who acquired Igenomix USA?
Igenomix USA was acquired by Vitrolife.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
